| |
|
|
|
|
|
|
|||
|
Blood, Vol. 95 No. 4 (February 15), 2000:
pp. 1370-1377
IMMUNOBIOLOGY
From the Department of Internal Medicine II, Chiba University School
of Medicine, Chiba, Japan; Laboratory of Molecular Immunology, National
Heart, Lung, and Blood Institute, Bethesda, MD; AgResearch, Ruakura,
Hamilton, New Zealand; and Department of Immunology, Institute of
Medical Science, University of Tokyo, Japan.
Antigen-induced eosinophil recruitment into the airways of
sensitized mice is mediated by CD4+ T cells and their
cytokines, especially IL-5. In this study, we found that the
antigen-induced airway eosinophilia was diminished in Stat5a-deficient
(Stat5a
Allergic late-phase reactions provoked by specific
antigens are associated with intense eosinophil infiltration into the
site of antigen administration.1-3 In addition to the
infiltration of eosinophils, there is an increase in CD4+ T
cells and interleukin-5 (IL-5)-producing cells at the sites of
late-phase reactions,4,5 suggesting that CD4+ T
cells and IL-5 might be involved in antigen-induced eosinophil recruitment into the tissue. In a murine model of airway late-phase reaction, we and others have provided direct evidence that
CD4+ T cells and IL-5 mediate antigen-induced eosinophil
recruitment into the tissue of sensitized mice.6,7
Conversely, endogenous IFN- IL-5 has been reported to activate a number of kinases, including Jak2,
Lyn, Syk, and Raf-1, as well as the phosphatase, Shp2.9-12 Among these molecules, Jak2 has been shown to be essential for eosinophil development13 and for the prevention of mature
eosinophil apoptosis.10 In addition, administration of Jak2
inhibitor, AG490,14 prevents antigen-induced eosinophil
recruitment into the airways (Kumano et al, in preparation), suggesting
that Jak2 activation is required for IL-5-induced tissue eosinophilia.
However, the interpretation of these experiments with AG490 must be
evaluated with caution because AG490 inhibits Jak3 as well as
Jak2.15
In the IL-5 signaling pathway, the most well-studied signaling
molecules downstream of Jak2 are Stat5a and Stat5b, 2 highly related
signal transducers and activators of transcription (STAT proteins).16-18 STAT proteins are cytosolic latent
transcription factors that are rapidly activated after cellular
exposure to interferons, cytokines, or growth factors.16-18
Stat5 was originally identified as a mammary gland factor
(MGF)-induced by prolactin.19 Subsequently, this protein
was renamed Stat5a when a second, homologous gene, denoted Stat5b, was
identified.18 Both Stat5a and Stat5b are activated not only
by prolactin, but also by a very wide range of other cytokines,
including IL-5.20 Although Stat5a and Stat5b are highly
homologous, the specificities of their actions are demonstrated by the
observations that Stat5a-deficient (Stat5a Although IL-5 is essential for antigen-induced eosinophil
recruitment into the airways6,7 and IL-5 activates
Stat5a and Stat5b,20 the role of Stat5a and Stat5b in
allergic inflammation remains unclear. Therefore, we have now analyzed
the allergic properties of Stat5a Mice and genetic analysis
Immunization
Antigen-induced eosinophil and T-cell infiltration in mouse airways The eosinophil infiltration into the airways was induced by the inhalation of antigen in sensitized mice, and the number of eosinophils infiltrating into the submucosal tissue of trachea was evaluated as described previously.6 Briefly, the sensitized mice were given aerosolized OVA (50 mg/mL) dissolved in 0.9% saline by a DeVilbiss 646 nebulizer (DeVilbiss Corp, Somerset, PA) for 20 minutes. As a control, 0.9% saline alone was administered by the nebulizer. At 24 or 48 h after the inhalation, the tracheas were excised, fixed in 10% buffered-formalin, and embedded in paraffin. The specimens (3 µm thick) were stained with Luna solution and hematoxylin-eosin solution. The number of eosinophils in the submucosal tissue of trachea was counted in Luna-stained sections and expressed as the number of eosinophils per the length of the basement membrane of trachea, which was measured with a digital curvimeter.IL-5 levels in BALF The BALF was centrifuged at 400g for 5 minutes at 4°C, and the amount of IL-5 in the supernatant was measured by the enzyme immunoassay, according to the manufacturer's instruction (PharMingen, San Diego, CA). The assays were performed in duplicate.Antigen-induced cytokine production and proliferation in splenocytes The spleen was removed from OVA-sensitized mice and a single cell suspension of splenocytes was prepared. Splenocytes (2 × 105) were then suspended in 200 µL of RPMI 1640 medium supplemented with 10% FCS (GIBCO BRL, Rockville, MD), 10 mmol/L glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin and were cultured in triplicate in the absence or presence of OVA (200 µg/mL) in a 96-well microtiter plate for 72 hours. In some experiments, splenocytes (2 × 105) were also cultured for 72 hours in a 96-well microtiter plate coated with 5 µg/mL of anti-CD3 mAb (145-2C11, PharMingen). The culture
supernatant was collected and the amounts of IL-4, IL-5, and IFN-
were determined by enzyme-linked immunosorbent assay (ELISA) according
to the manufacturer's instructions (PharMingen). For proliferation
assays, splenocytes (2 × 105) were cultured in the
same conditions as described previously, with 1 µCi (0.037 MBq)
3H] thymidine added for the final 16 hours.
Determination of antigen-specific IgE antibody in serum Two weeks after the second immunization, the titer of OVA-specific IgE antibody in mouse serum was assessed by a 24-hour passive cutaneous anaphylaxis (PCA) reaction as described by Ovary.29Determination of antigen-specific IgG1 and IgG2a antibodies in serum The amount of OVA-specific IgG1 and IgG2a in serum was measured by ELISA as described elsewhere.30 In brief, ELISA plates were coated with OVA (250 µg/mL), washed 3 times with PBS containing 0.05% Tween20 (PBST), and blocked with blocking buffer (PBS containing 2% bovine serum albumin [BSA; Sigma Chemical Co]). Serum samples were added to the wells after 1:1000 or 1:3000 dilution in blocking buffer. As a control, serial dilution of pooled serum from OVA-sensitized wild-type mice were analyzed in each plate. After 1-hour incubation, wells were washed with PBST, added either biotinylated antimouse IgG1 (PharMingen) or biotinylated antimouse IgG2a (PharMingen) at 2 µg/mL in blocking buffer, and incubated for 1 hour. After washing, wells were incubated with 100 µL of ExtrAvidin alkaline phosphatase (1:2000 dilution, Sigma Chemical Co, St Louis, MO) for 45 minutes, washing with PBST, and the reaction was developed with pNPP (Sigma Chemical Co).IL-5-induced eosinophilopoiesis IL-5-induced eosinophilopoiesis was analyzed as described previously.26 In brief, mice were injected intraperitoneally with 20 000 U of recombinant murine IL-5 (rmIL-5)26 daily for 4 days. Forty-eight hours after the fourth administration of rmIL-5, mice were killed and cell differentials in bone marrow, peripheral blood, and peritoneal cavity were determined by counting 500 cells stained with Wright-Giemsa solution. A part of the cells in the peritoneal cavity were subjected to a flow cytometric analysis for the surface phenotyping of VLA-4 and Gr-1 as described below.Flow cytometric analysis Cells from the BALF and peritoneal cavity were stained and analyzed on a FACScaliber (Becton Dickinson, San Jose, CA) with CELLQuest software.24 For direct staining, the following conjugated antibodies were purchased from PharMingen: anti-CD4 FITC (H129.19), anti-CD8 APC, 53-6.7 anti-VLA-4 FITC (R1-2), and anti-Gr-1 APC (RB6-8C5). Before staining, Fc receptors were blocked with anti-CD16/32 antibody (2.4G2, PharMingen).Data analysis Data are summarized as mean ± SD. The statistical analysis of the results was performed by the unpaired t test. P values < .05 were considered significant.
Antigen-induced eosinophil recruitment into the airways is
diminished in Stat5a / ) mice and in
Stat5b-deficient (Stat5b / ) mice. As shown in
Figure 1A, antigen-induced eosinophil
infiltration into the trachea at 24 hours after antigen inhalation was
severely diminished in both Stat5a / mice and
Stat5b / mice by 85% and 84%, respectively
(wild-type mice 17.2 ± 5.2, Stat5a /
mice 2.5 ± 1.4, and Stat5b / mice
2.8 ± 1.0 eosinophils/mm, mean ± SD, n = 8 mice in each group, P < .001). Antigen-induced eosinophil infiltration
into the trachea at 48 hours was also significantly diminished in
Stat5a / mice and
Stat5b / mice (data not shown). Consistent
with diminished antigen-induced eosinophil infiltration in the trachea,
the number of eosinophils recovered in BALF at 36 hours after antigen
inhalation was also significantly decreased in
Stat5a / mice and
Stat5b / mice by 70% and 74%, respectively
(n = 5, P < .005) (Figure 1B).
Antigen-induced T-cell recruitment into the airways is diminished in
Stat5a / mice and
Stat5b / mice by 64% and 61%, respectively
(n = 5, P < .005) (Figure 2). In addition, consistent with diminished CD4+ T-cell
infiltration in the airways, IL-5 levels in the BALF at 24 hours after
antigen challenge were decreased in Stat5a /
mice and Stat5b / mice by 57% and
59%, respectively (wild-type mice 549 ± 98,
Stat5a / mice 239 ± 90, and
Stat5b / mice 227 ± 86 pg/mL, n = 5,
P < .005) (Figure 3). Taken
together, these results suggest that both Stat5a and Stat5b are
required for antigen-induced eosinophil and T-cell recruitment into the airways and that diminished antigen-induced eosinophil recruitment in
Stat5a / mice and
Stat5b / mice results in part from impaired
IL-5 production in the airways.
Antigen-induced IL-4 and IL-5 production is decreased in
Stat5a / mice and
Stat5b / mice. As shown in Table
1, IL-4 and IL-5 production from antigen (OVA)-stimulated splenocytes was undetectable in
Stat5a / mice and
Stat5b / mice, whereas antigen-stimulated
wild-type splenocytes produced substantial amounts of IL-4 and IL-5
(n = 5, P < .01). Similarly, IFN- production from
antigen-stimulated splenocytes was undetectable in
Stat5a / mice and
Stat5b / mice but was readily detected in
antigen-stimulated wild-type splenocytes (n = 5, P < .01)
(Table 1).
Antigen-induced T-cell proliferation is decreased in
Stat5a / mice and
Stat5b / mice by 79% and 81%, respectively
(n = 5, P < .005) (Figure
4A). This defect may account for the
diminished antigen-induced T-cell infiltration into the airways (Figure
2). In contrast to the diminished antigen-induced proliferation,
anti-CD3-induced proliferation of splenocytes was normal in
Stat5a / mice and slightly decreased (but not
statistically significant) in Stat5b / mice
(n = 5) (Figure 4B). These results suggest that Stat5a and Stat5b
might be required for the generation of antigen-specific T-cell pools
in the periphery.
Antigen-specific IgE production is diminished in
Stat5a / mice and
Stat5b / mice at 2 weeks after the second
immunization. Interestingly, Stat5a / mice
exhibited decreased levels of antigen-specific IgE production (n = 10, P < .005), whereas antigen-specific IgE
production was normal in Stat5b / mice (Figure
5A). In addition, antigen-specific IgG1
production was also diminished in Stat5a /
mice (n = 10, P < .01) (Figure 5B), suggesting that
systemic Th2 response was diminished in
Stat5a / mice but not in
Stat5b / mice. In contrast to the diminished
IgE and IgG1 production in Stat5a / mice,
antigen-specific IgG2a production was increased in
Stat5a / mice (n = 10, P < .005)
(Figure 5C), suggesting the Th1-polarized immune responses in
Stat5a / mice.
IL-5-induced eosinophilopoiesis is diminished in
Stat5a / mice and
Stat5b / mice (Figure 1) presumably results in
part from diminished IL-5 production in the airways (Figure 3), the
defect in eosinophil recruitment into the airways appeared more severe
than the defect in IL-5 production. We therefore investigated whether
IL-5-dependent eosinophilopoiesis was normal in
Stat5a / mice and
Stat5b / mice. To address this issue,
Stat5a / mice and
Stat5b / mice were injected intraperitoneally
with recombinant murine IL-5 (rmIL-5; 20 000 U/d) for 4 days and the
eosinophil numbers in the bone marrow, peripheral blood, and peritoneal
cavity were determined at 48 hours after the last injection. The
administration of rmIL-5 significantly increased eosinophil numbers in
the bone marrow in wild-type mice (n = 5) (Figure
6A). In Stat5a /
mice and Stat5b / mice; however, the magnitude
of the IL-5-induced eosinophilia in the bone marrow was approximately
half of that in rmIL-5-treated wild-type mice (n = 5,
P < .005) (Figure 6A). These results indicate that both
Stat5a and Stat5b play a role in IL-5-dependent eosinophilopoiesis.
It has been shown that antigen-induced eosinophil
recruitment into the airways of sensitized mice is mediated by the Th2
subset of CD4+ T cells and subsequent secretion of
IL-5.6 In this study, we showed that both Stat5a and Stat5b
were required for antigen-induced eosinophil and T-cell recruitment
into the airways. We found that antigen-induced eosinophil infiltration
in the airways and antigen-induced CD4+ T-cell infiltration
and IL-5 production in the airways were diminished in both
Stat5a We thank Drs L. Hennighausen and X. Liu for Stat5a-deficient mice and
K. Kurasawa, M. Nishimura, T. Sato, K. Hirano, T. Matsui, and M. Watanabe for technical help.
Submitted August 16, 1999; accepted October 8, 1999.
Supported in part by grants from the Ministry of Education,
Science and Culture, Japan, and from ASTRA Japan Co.
S-i.K. and H.N. contributed equally to this work.
Reprints: Dr Hiroshi Nakajima, Department of Internal
Medicine II, Chiba University School of Medicine, 1-8-1 Inohana, Chiba
City, Chiba 260-8670, Japan; e-mail:
nakajimh{at}intmed02.m.chiba-u.ac.jp.
The publication costs of this
article were defrayed in part by
page charge payment. Therefore,
and solely to indicate this fact,
this article is hereby marked
"advertisement"
in accordance with 18 U.S.C.
section 1734.
1.
Gleich GJ.
The eosinophil and bronchial asthma: current understanding.
J Allergy Clin Immunol.
1990;85:422[Medline]
[Order article via Infotrieve].
2.
Gleich GJ, Adolphson CR, Leiferman KM.
The biology of the eosinophilic leukocyte.
Annu Rev Med.
1993;44:85[Medline]
[Order article via Infotrieve].
3.
Wills-Karp M.
Immunologic basis of antigen-induced airway hyperresponsiveness.
Annu Rev Immunol.
1999;17:255[Medline]
[Order article via Infotrieve].
4.
Robinson DS, Hamid Q, Ying S, et al.
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.
N Engl J Med.
1992;326:298[Abstract].
5.
Wardlaw AJ, Moqbel R, Kay AB.
Eosinophils: biology and role in disease.
Adv Immunol.
1995;60:151[Medline]
[Order article via Infotrieve].
6.
Nakajima H, Iwamoto I, Tomoe S, et al.
CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea.
Am Rev Respir Dis.
1992;146:374[Medline]
[Order article via Infotrieve].
7.
Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG.
Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.
J Exp Med.
1996;183:195
8.
Iwamoto I, Nakajima H, Endo H, Yoshida S.
Interferon
9.
Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon HU.
Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils.
J Exp Med.
1996;183:1407
10.
Pazdrak K, Olszewska-Pazdrak B, Stafford S, Garofalo RP, Alam R.
Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation.
J Exp Med.
1998;188:421
11.
Pazdrak K, Adachi T, Alam R.
Src homology 2 protein tyrosine phosphatase (SHPTP2)/Src homology 2 phosphatase 2 (SHP2) tyrosine phosphatase is a positive regulator of the interleukin 5 receptor signal transduction pathways leading to the prolongation of eosinophil survival.
J Exp Med.
1997;186:561
12.
Adachi T, Alam R.
The mechanism of IL-5 signal transduction.
Am J Physiol.
1998;275:C623
13.
Parganas E, Wang D, Stravopodis D, et al.
Jak2 is essential for signaling through a variety of cytokine receptors.
Cell.
1998;93:385[Medline]
[Order article via Infotrieve].
14.
Meydan N, Grunberger T, Dadi H, et al.
Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor.
Nature.
1996;379:645[Medline]
[Order article via Infotrieve].
15.
Wang LH, Kirken RA, Erwin RA, Yu CR, Farrar WL.
JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
J Immunol.
1999;162:3897
16.
Schindler C, Darnell JE Jr.
Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.
Annu Rev Biochem.
1995;64:621[Medline]
[Order article via Infotrieve].
17.
Leonard WJ.
STATs and cytokine specificity.
Nature Med.
1996;2:968[Medline]
[Order article via Infotrieve].
18.
Leonard WJ, O'Shea JJ.
Jaks and STATs: biological implications.
Annu Rev Immunol.
1998;16:293[Medline]
[Order article via Infotrieve].
19.
Wakao H, Gouilleux F, Groner B.
Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response.
EMBO J.
1994;13:2182[Medline]
[Order article via Infotrieve].
20.
Mui AL, Wakao H, O'Farrell AM, Harada N, Miyajima A.
Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologues.
EMBO J.
1995;14:1166[Medline]
[Order article via Infotrieve].
21.
Liu X, Robinson GW, Wagner K-U, Garrett L, Wynshaw-Boris A, Hennighausen L.
Stat5a is mandatory for adult mammary gland development and lactogenesis.
Genes Develop.
1997;11:179
22.
Udy GB, Towers RP, Snell RG, et al.
Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression.
Proc Natl Acad Sci USA.
1997;94:7239
23.
Imada K, Bloom ET, Nakajima H, et al.
Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity.
J Exp Med.
1998;188:2067
24.
Nakajima H, Liu XW, Wynshaw-Boris A, et al.
An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor
25.
Moriggl R, Topham DJ, Teglund S, et al.
Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells.
Immunity.
1999;10:249[Medline]
[Order article via Infotrieve].
26.
Yoshida T, Ikuta K, Sugaya H, et al.
Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R-deficient mice.
Immunity.
1996;4:483[Medline]
[Order article via Infotrieve].
27.
Kopf M, Brombacher F, Hodgkin PD, et al.
IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses.
Immunity.
1996;4:15[Medline]
[Order article via Infotrieve].
28.
Iwamoto I, Kumano K, Kasai M, Kurasawa K, Nakao A.
Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways.
Am J Respir Crit Care Med.
1996;154:1257[Abstract].
29.
Ovary Z.
Passive cutaneous anaphylaxis. In:
Weir DM, ed.
Handbook of Experimental Immunology. Vol 1. Oxford: Blackwell Scientific Publications; 1986:33.1-33.9.
30.
Renz H, Smith HR, Henson JE, Ray BS, Irvin CG, Gelfand EW.
Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse.
J Allergy Clin Immunol.
1992;89:1127[Medline]
[Order article via Infotrieve].
31.
Smith KA.
Interleukin-2: inception, impact, and implications.
Science.
1988;240:1169
32.
Wakao H, Harada N, Kitamura T, Mui AL, Miyajima A.
Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways.
EMBO J.
1995;14:2527[Medline]
[Order article via Infotrieve].
33.
Gilmour K, Pine R, Reich NC.
Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes.
Proc Natl Acad Sci USA.
1995;92:10,772
34.
Lin JX, Migone TS, Tsang M, et al.
The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.
Immunity.
1995;2:331[Medline]
[Order article via Infotrieve].
35.
Paul WE, Seder RA.
Lymphocyte responses and cytokines.
Cell.
1994;76:241[Medline]
[Order article via Infotrieve].
36.
Wise JT, Baginski TJ, Mobley JL.
An adoptive transfer model of allergic lung inflammation in mice is mediated by CD4+CD62LlowCD25+ T cells.
J Immunol.
1999;162:5592
37.
Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CG.
Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice.
J Exp Med.
1997;185:885
38.
Walsh GM, Mermod JJ, Hartnell A, Kay AB, Wardlaw AJ.
Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is
39.
Roboz GJ, Rafii S.
Interleukin-5 and the regulation of eosinophil production.
Curr Opin Hematol.
1999;6:164[Medline]
[Order article via Infotrieve].
40.
Nishinakamura R, Nakayama N, Hirabayashi Y, et al.
Mice deficient for the IL-3/GM-CSF/IL-5
41.
Miyajima A, Kitamura T, Harada N, Yokota T, Arai K.
Cytokine receptors and signal transduction.
Annu Rev Immunol.
1992;10:295[Medline]
[Order article via Infotrieve].
42.
Feldman GM, Rosenthal LA, Liu X, et al.
STAT5a-deficient mice demonstrated a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression.
Blood.
1997;90:1768
43.
Teglund S, McKay C, Schuetz E, et al.
Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.
Cell.
1998;93:841[Medline]
[Order article via Infotrieve].
44.
Yamaguchi Y, Hayashi Y, Sugama Y, et al.
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.
J Exp Med.
1988;167:1737
45.
Lischke A, Moriggl R, Brandlein S, et al.
The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common
46.
de Vries JE.
The role of IL-13 and its receptor in allergy and inflammatory responses.
J Allergy Clin Immunol.
1998;102:165[Medline]
[Order article via Infotrieve].
47.
Zuany-Amorim C, Ruffi C, Hail S, Vargaftig BB, Pereira P, Pretolani M.
Requirement for
48.
Walker C, Checkel J, Cammisuli S, Leibson PJ, Gleich GJ.
IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation.
J Immunol.
1998;161:1962
49.
Korsgren M, Persson CG, Sundler F, et al.
Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice.
J Exp Med.
1999;189:553
50.
Kuperman D, Schofield B, Wills-Karp M, Grusby MJ.
Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production.
J Exp Med.
1998;187:939
51.
Akimoto T, Numata F, Tamura M, et al.
Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice.
J Exp Med.
1998;187:1537
52.
Takeda K, Tanaka T, Shi W, et al.
Essential role of Stat6 in IL-4 signaling.
Nature.
1996;380:627[Medline]
[Order article via Infotrieve].
53.
Shimoda K, van Deursen J, Sangster MY, et al.
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.
Nature.
1996;380:630[Medline]
[Order article via Infotrieve].
54.
Kaplan MH, Schindler U, Smiley ST, Grusby MJ.
Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.
Immunity.
1996;4:313[Medline]
[Order article via Infotrieve].
55.
Wills-Karp M, Luyimbazi J, Xu X, et al.
Interleukin-13: central mediator of allergic asthma.
Science.
1998;282:2258
56.
Grunig G, Warnock M, Wakil AE, et al.
Requirement for IL-13 independently of IL-4 in experimental asthma.
Science.
1998;282:2261
57.
Thierfelder WE, van Deursen JM, Yamamoto K, et al.
Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells.
Nature.
1996;382:171[Medline]
[Order article via Infotrieve].
58.
Kaplan MH, Sun YL, Hoey T, Grusby MJ.
Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice.
Nature.
1996;382:174[Medline]
[Order article via Infotrieve].
59.
Gavett SH, O'Hearn DJ, Li X, Huang S-K, Finkelman FD, Wills-Karp M.
Interleukin-12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.
J Exp Med.
1995;182:1527
60.
Sampath D, Castro M, Look DC, Holtzman MJ.
Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma.
J Clin Invest.
1999;103:1353[Medline]
[Order article via Infotrieve].
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2000 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||